Techstars is a global platform that provides investment and innovation. Through the Techstars Worldwide Entrepreneur Network, founders and their teams connect with other entrepreneurs, experts, mentors, alumni, investors, community leaders, and corporate partners who will help their companies grow. Techstars operates four divisions: Techstars Mentorship-Driven Accelerator Program supercharges success and Techstars Startup Programs inspire, educate, and connect entrepreneurs. Techstars Venture Capital Fund invests in innovative and disruptive companies. Techstars Corporate Innovation Partnerships help brands create products and services. Techstars' accelerator portfolio includes more than 1,000 companies with a market cap of $8.1 billion.

Techstars

We Back Builders. Founded by @Jason  Team behind   This Week in Startups: https://www.youtube.com/c/ThisWeekIn  @twistartups    The LAUNCH Accelerator https://launchaccelerator.co/ @launchincubator    The Syndicate https://thesyndicate.com/ @thesyndicate415    Founder university: https://www.founder.university/ @founderuni    Remote Demo Day  https://remotedemoday.com/ @remotedemoday

LAUNCH

We currently host three syndicates:  Jason's Syndicate Deals are selected and shared by Jason Calacanis. The SaaS Syndicate Our latest syndicate, launching on November 1st, focuses on software-as-a-service. The All-In Syndicate Deals are selected by three members of the All-In Podcast (Chamath Palihapitiya, David Friedberg, and Jason Calacanis).

The Syndicate.com

Milkbox Partners is an angel investment and advisory firm. Based in New York, the firm primarily makes investments in early stage companies.

Milkbox Partners

Bioverge is a venture capital firm specializing in emerging healthcare startups. The firm operates an investment platform that aims to democratize access to startups solving healthcare’s biggest challenges and accelerating their progress.

Bioverge

s16vc is an early-stage founder-centric angel fund. The fund focuses on early stage technology investments, operating globally in Europe, and the US. We have brought together more than 80 founders & operators to support early stage companies in their growth.  Fund partners are active founders and operators:  - Oleg Bibergan - Co-founder & Co-Managing Partner at s16vc, venture investor & corporate finance executive with 15 years of experience spanning early, growth, and late stage deals as equity investor with GS SSG, Kismet Capital Group, and personal angel portfolio - Aleks Shamis - Co-founder & Co-Managing Partner at s16vc. Ex-Deputy CEO at Borzodelivery.com (global on-demand delivery business, operating in 10 countries) - Mike Peregudov - Founder & CEO at Pivot.ws (EdTech startup in the US market), Food Party (exit to Yandex)   - Leo Batalov - Partner, Global Co-Head of Emerging Growth Companies & Venture Capital at DLA Piper, top international law firm - Egor Rudi - Founder & CEO at Profi.ru (leading services marketplace in Eastern Europe), Co-founder at Hands.ru (first Uber-like marketplace in home improvement market) - Tolya Marin - Founder at Payment systems (fintech company with profit per employee > PayPal & 20m installs/ 5m MAU) - Andrey Khusid - Founder and CEO of Miro, the world's most popular visual collaboration platform Being founders ourselves, we are confident that people succeed, not ideas, and feel immense respect for every founder who perseveres to the point of creating impact and monetizable value.  We invest in teams who share our values:  -  People succeed, not ideas - Community, not individual - Trust - Transparency - Intrinsic motivation to help - Pay forward - Beginner mindset

s16vc

Private investor focused on promising founders building globally scalable, disruptively efficient, digital properties where we can estimate 10X return within 10 years before dilution. We syndicate, lead and provide alternative financing to portfolio companies.

Standing Oaks Venture Partners

1315 Capital provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, the latter including businesses focused on cost containment and digital health.  We believe that these investment areas are attractive largely due to numerous niche market sub-segments and business models where high-quality management teams can rapidly grow small platform companies, in a capital efficient way, into large and important businesses.  The firm targets $10-$20 million investments in commercial healthcare entities that have the potential to scale to approximately $100 million of revenue, a highly attractive level for acquisition or to access the public markets.

1315 Capital

Davidovs Venture Collective is a VC firm based on a community of 99+ founders (including 4 active unicorn founders), operators, and angel investors. They are engineers with a lot of experience running startups and being value-added investors. DVC invests small entry checks from the rolling fund and follows up with bigger sums along the way. DVC pools together its collective network, expertise, and resources to help its portfolio companies. DVC's investment focus is quite broad, but DVC prefers partnering with experienced and repeat founders.

Davidovs Venture Collective

Apply to join the syndicate at: https://angel.co/laborcapital/syndicate

Labor Capital

NutriSense

NutriSense is a health and wellness platform that monitors blood glucose levels in real-time with CGM and a tracking app. It personalizes nutrition by leveraging state-of-the-art continuous glucose monitoring and machine learning technology. The company's mission is to help anybody discover and reach their health potential. NutriSense was founded in 2019 and is based in Chicago, Illinois.

NutriSense is a chronic care management company that provides individualized dietitian coaching, along with continuous glucose monitoring data to improve metabolic health. NutriSense’s tailored programs include a continuous glucose monitor (CGM) that tracks blood glucose levels 24/7 and access to a registered dietician for guidance. Data gathered from the device is sent to the Nutrisense app, where users can view their real-time data, interact with experts, and track the impact of meals, activity, habits, stress, and sleep on glucose levels.

Membership-based, non-insurance healthcare companies helping maintain a steady state of well being.

Preventive Healthcare

NutriSense is a health technology company based in Chicago that aims to help individuals take a preventive approach to metabolic health. Founded in 2019 by Alex Skryl, Kara Collier, and Dan Zavortony, the company offers a program that combines continuous glucose monitoring (CGM) devices with personalized dietitian support.

Consider These Lab Tests to Maintain Good Metabolic Health

Best Continuous Glucose Monitor Programs in 2024

Is the Levels CGM Program Worth It?

Signos vs. Nutrisense vs. Levels: Comparing CGM Devices

Nutrisense review: a pricey way to learn a little

Continuous glucose monitor (CGM) App Comparison: Levels, Veri, Nutrisense, and January.ai

Nutrisense Review

NutriSense Raises $25M for Sensors That Track Glucose Levels

Our Mission Is To Help Anyone Reach Their Health Potential.

Functional Nutrition

2424: Nutrisense – Smart insights into your unique body with CGMs

NutriSense is a chronic care management company that provides individualized dietitian coaching, along with continuous glucose monitoring data to improve metabolic health. NutriSense’s tailored programs include a continuous glucose monitor (CGM) that tracks blood glucose levels 24/7 and access to a registered dietician for guidance. Data gathered from the device is sent to the Nutrisense app, where users can view their real-time data, interact with experts, and track the impact of meals, activity, habits, stress, and sleep on glucose levels.The firm operates a D2C business model, offering a one-month subscription priced at USD 225–399 per month depending on an individual's goals. After the first month, the firm charges an additional USD 50 per month for its text-based dietician service.Key customers and partnershipsAs of May 2024, it had over 70,000 users subscribed to its service.Funding and financialsThe company received its most recent investment in July 2022 in a USD 25 million Series A funding round led by 1315 Capital. The funds were allocated to expand its operational team and its market presence among new members.

Cardiomo Care is developing noninvasive wearable devices to alert users and caretakers when there are abnormalities in the heartbeat. The company’s AI engine, trained on existing and growing data sets, can predict potential heart issues up to two hours before they occur, enabling early detection and intervention for arrhythmias and other cardiovascular diseases (CVDs).The company's product, CardiomoPatch, is a waterproof, wearable patch capable of long-term wear with a 10-day battery life. The patch monitors a patient's cardiac data, including ECG outputs, breathing, and skin temperature, and transmits the data via a mobile app for analysis by Cardiomo's AI engine.&nbsp;As of May 2024, the company is yet to commercialize its product and has over 1,600 pre-orders.

Cardiomo Care

Omada is a prevention-focused digital therapeutics startup that helps members achieve health goals through lifestyle changes. It offers four evidence-based, virtual prevention programs for managing hypertension, musculoskeletal (MSK) issues, prediabetes, and diabetes.Omada offers real-time data tracking through connected devices (such as wireless scales, blood pressure, and glucose monitors) and access to personalized coaching sessions via a mobile app as part of its prevention program. It also provides an online community of peers with similar health conditions to discuss challenges and provide support. In May 2021, Omada became the first fully-virtual healthcare provider to earn the National Committee for Quality Assurance’s Population Health Program Accreditation for its type 2 diabetes and type 2 diabetes + hypertension programs.Unlike its peers, Omada operates a performance-based business model where it charges clients an enrollment fee based on the number of users and a performance fee based on how much weight their employees lose. In May 2020, the company acquired virtual physical therapy startup Physera.Key customers and partnershipsAs of May 2024, Omada had more than 1 million members from more than 1,900 enterprise clients across all 50 US states. Its B2B employer and health plan client base include key clients such as American Eagle, Kaiser Permanente, Costco Wholesale, 3M, and Marvin. Additionally, the company has partnered with health systems and hospitals such as Intermountain Healthcare to provide its preventive programs as a covered benefit.In <a href="https://sp-edge.com/updates/15587">January 2023</a>, the company partnered with health service company Castell (a subsidiary of Intermountain Healthcare) to provide its diabetes programs to members from Intermountain Healthcare’s primary care providers in its Utah Medical Group. Further in <a href="https://sp-edge.com/updates/25245">January 2024</a>, the company partnered with Amazon to expand access to its cardiometabolic program.

Omada Health

VillageMD provides primary care services for patients. It also provides tools, technology, and staffing support needed for physicians to deliver high-quality services. VillageMD’s service delivery methods include traditional freestanding clinics, Village Medical at Walgreens co-located clinics, as well as at-home and around-the-clock virtual visits. It also leverages a team-based approach to care where physicians lead nurse practitioners, pharmacists, mental health specialists, and dietitians to offer a holistic care program. The technology of VillageMD includes docOS, an operating system that enables better patient care by connecting various clinical source systems with ongoing patient-generated data coupled with an AI engine to continuously analyze messages to enable patient self-care.The company made several acquisitions to expand its footprint: 1) <a href="https://sp-edge.com/updates/14347">Summit Health</a> for USD 8.9 billion in November 2022, 2) Healthy Interactions, an interactive patient education platform, in February 2022, and 3) <a href="https://sp-edge.com/updates/16968">Starling Physicians</a>, a primary care and specialty care provider, in March 2023.Key customers and partnershipsIn June 2020, VillageMD and Walgreens Boots Alliance announced a collaborative effort to open at least 600 Village Medical centers at Walgreens across more than 30 US markets by 2025. Walgreens invested USD 5.2 billion in VillageMD (from the previously announced USD 1.0 billion), raising its ownership stake to 63% (from 30%).However, as of May 2024, Walgreens had plans to close 160 VillageMD clinics as part of a cost-cutting plan.

VillageMD

Cityblock Health is a value-based healthcare provider focused on delivering comprehensive care to underserved communities, primarily Medicaid and lower-income Medicare beneficiaries. The company combines primary care, behavioral health, and social services to address the complex physical, mental, and social needs of its members.Cityblock's model involves partnering with local community-based organizations and deploying multidisciplinary care teams that include doctors, nurses, behavioral health specialists, and community health workers. These teams provide personalized care through 24/7 access to multi-modal care delivery, including in-home visits, telehealth, and community health hubs.The services of Cityblock are available to members at no additional cost if they are covered by an eligible health plan.Key Customers and PartnershipsAs of May 2024, the company’s services were available in seven states across the US and served over 100,000 members.In May 2024, it partnered with <a href="https://sp-edge.com/updates/29647">Sunshine Health</a> to expand to Florida, and, in <a href="https://sp-edge.com/updates/13270">September 2022</a>, it partnered with MDwise to expand into Indiana. Prior to that, the company had partnered with insurance providers such as ConnectiCare (Connecticut), Tufts Health Plan (Massachusetts), Emblem Health (New York), Healthy Blue (North Carolina), Molina Healthcare (Ohio) and CareFirst (Washington DC).Funding and FinancialsCityblock is a spin-off of Sidewalk Labs, an Alphabet company that incubates and invests in tech companies and products to improve urban infrastructure. It completed a USD 400 million Series D funding round led by Softbank in <a href="https://sp-edge.com/updates/5326">September 2021</a>, valuing the company at USD 5.7 billion. The funds were used to expand its services.

Cityblock Health

Everside Health (formerly Paladina Health) offers preventative care for chronic conditions and primary, mental and occupational healthcare treatments for acute conditions. Patients benefit from around-the-clock access to care, same-day or next-day appointments for in-person, and virtual care visits with zero copays.Everside aims to generate around 17% healthcare cost savings in three years and 31% in five years for its corporate members by leveraging a data-driven approach to care coordination.The company leverages data from past medical records, predictive analytics, and AI in the delivery of preventative care services.Founded in 2010 under the name Paladina Health, the company was rebranded in November 2020 as Everside Health following a merger between three primary care groups (Paladina, Activate Healthcare, and Healthstat). Furthermore, in February 2024, Everside Health merged with primary care provider Marathon Health to form a combined entity that would operate as Marathon Health, and, as of May 2024, the integration was ongoing.Key customers and partnershipPost-merger with Marathon Health, the combined entity would serve 2.5 million patients through over 680 clinics across 41 states.Funding and financialsThe company received its most recent investment in July 2022, amounting to USD 164 million in growth equity funding. The round was led by New Enterprise Associates (NEA). The funds were allocated toward growing its market presence and exploring opportunities for M&amp;A as well as to enhance and improve its product features. Additionally, the firm planned to expand its coverage of specialty care services aimed at individuals, employers, and union organizations.

Everside Health

Platforms offer a subscription-based or B2B-sponsored, evidence-based program for managing a specific long-term health condition.

DPCs offer value-based primary and preventive care services addressing whole-person (social, mental, physical) needs for a fixed monthly or annual fee paid by either the patient, insurance provider, or employer.

Companies offer B2B and D2C evidence-based treatments delivered via software programs to prevent and manage a variety of chronic conditions.

Tools that collect and analyze real-time patient data that supports healthcare providers with clinical decisions,  improves patient outcomes, and reduces medical errors.

Companies offer independent physician practices and hospitals with the tools (patient engagement, care coordination, administrative services) to help manage and improve clinical health outcomes of a defined group of individuals or large populations.

Platforms are used to track and gather patient health-related information via either a connected device or at-home test kits to detect the early onset of disease and identify any abnormalities in readings—but do not include a treatment plan.

To gather large amounts of real-time data for chronic care management, DTx, and patient monitoring

XR used by some startups for chronic pain management

Offers digital means of providing direct primary care, passive remote monitoring, chronic care management, etc.

AI/ML is used in predictive analytics, diagnostics tools, and population management

Offers tailored preventive interventions and treatments to the specific needs and characteristics of each individual

NutriSense is a health technology company based in Chicago that aims to help individuals take a preventive approach to metabolic health. Founded in 2019 by Alex Skryl, Kara Collier, and Dan Zavortony, the company offers a program that combines continuous glucose monitoring (CGM) devices with personalized dietitian support.
NutriSense's program involves users wearing a CGM sensor on their upper arm, which measures glucose levels in the interstitial fluid. The sensor data is transmitted to the NutriSense app, providing real-time insights into how an individual's blood sugar levels respond to food, exercise, sleep, and other factors. The app also provides detailed analytics, including glucose scores, meal scores, and averages for different periods.
Unlike traditional CGM usage for diabetes management, NutriSense positions its program as a tool for overall wellness and achieving various health goals, such as weight loss, athletic performance optimization, and building long-term healthy habits. The program is designed for non-diabetic individuals and is not recommended for those on insulin therapy or undergoing cancer treatment.
NutriSense's key offering is the combination of CGM technology and personalized support from registered dietitians. During the first month of the program, users receive free one-on-one guidance from a NutriSense dietitian, who interprets the user's glucose data and provides actionable recommendations for diet, exercise, and lifestyle adjustments. After the first month, users can continue working with a dietitian for an additional monthly fee.
The company's mission is to help individuals discover and reach their health potential by providing access to personal biometric data and expert guidance. NutriSense aims to empower users to make informed decisions about their health and build sustainable habits for optimal metabolic well-being.

Limbo is a digital weight loss and body transformation service that guides users to healthier habits by leveraging real-time biodata from wearables, including a continuous glucose monitor (CGM), an app, and a combination of human coaches and artificial intelligence (AI). The service is based on over 30 years of research by co-founder and physiologist Tony Martin, focused on understanding how blood glucose levels regulate the body's energy system.
Limbo's approach revolves around monitoring users' blood glucose levels and providing personalized feedback and nudges to help them make better food choices and lifestyle adjustments. The goal is to flatten users' blood glucose levels, which Limbo refers to as the "Limbo line," by reducing the consumption of carbohydrates, sugars, and processed foods. This, in turn, is believed to promote weight loss and improve overall health.
The service involves wearing a CGM sensor, which continuously tracks users' glucose levels, and a smart wristband that monitors various biometrics, including heart rate, steps, and sleep patterns. Users also receive a smart scale to track their body weight, body fat, and muscle mass. This data is then analyzed by Limbo's AI system and human coaches, who provide tailored feedback and guidance through the Limbo app.
According to Limbo, early users have experienced an average body weight reduction of 12% within the first three months of using the service. The company claims that by helping users control their blood glucose levels and make better dietary choices, they can lose weight and improve their energy levels with relative ease.

Limbo

Oviva is a health-tech company that provides app-guided therapy programs to help individuals adopt healthier eating and lifestyle habits. Their programs combine personalized care led by healthcare professionals, including dietitians, nutritionists, doctors, health coaches, psychologists, and exercise therapists, with their proprietary digital tools.
Oviva's approach involves empowering users with knowledge to track and understand their physiological data, set personal goals, and receive reminders and nudges through the Oviva app. Users can record their weight, HbA1c levels, food intake, and connect wearable devices, enabling their coaches to provide tailored coaching based on tracked habits.
By delivering care remotely and digitally, Oviva can scale its services while reducing costs. An Oviva coach can handle 4,000 to 5,000 user contacts per year, compared to around 900 appointments in traditional settings. Their services are available in the UK, Germany, Switzerland, and France, with country-specific websites catering to local healthcare systems.
In March 2023, Oviva launched a multi-site solution, displaying market-specific websites based on the visitor's location through GeoIP redirection. This approach ensures a seamless user experience tailored to each country's requirements.
Oviva partners exclusively with the National Health Service (NHS) in the UK to offer free digital weight management programs to participants. These 12-week programs provide one-on-one coaching, access to the Oviva app for self-monitoring, and an online learning portal.

Oviva

ZOE is a personalized nutrition program that aims to provide tailored dietary recommendations based on an individual's biological responses to different foods. The program utilizes at-home testing kits to analyze factors such as blood sugar control, blood fat control, and gut microbiome composition.
The testing process involves eating standardized muffins while wearing a continuous glucose monitor, collecting a stool sample for microbiome analysis, and performing a finger-prick blood test. Based on the results of these tests, ZOE generates personalized food scores and meal recommendations through its app.
The program claims to offer insights into optimal nutrition for each individual, helping to reduce dietary inflammation, improve gut health, and support overall metabolic health. ZOE's approach is founded on the principle that people have inherent differences in their responses to various food groups, and personalized dietary guidance can address these variations.
ZOE's technology and algorithms are based on research studies, such as the PREDICT studies conducted by King's College London and other institutions, which have examined the variability in postprandial responses among individuals. The program aims to move beyond traditional calorie counting and provide a more personalized approach to nutrition.

Lifesum is a digital nutrition platform that helps users build healthier eating habits through its innovative app. Founded in Stockholm, Sweden in 2013, the company provides a comprehensive suite of features to track meals, habits, and body measurements, enabling users to achieve their health and wellness goals. As of June 2024, Lifesum has over 65 million users worldwide across 250 countries, supporting 11 languages.
The app offers a user-friendly food diary allowing users to log meals by searching a database, scanning barcodes, or manually entering items. It tracks calorie intake, hydration levels, exercise routines, and provides personalized diet plans tailored to individual preferences and objectives, such as ketogenic, high protein, Scandinavian, or Mediterranean diets. Lifesum's premium subscription unlocks additional features like detailed nutrient tracking, advanced analytics, and a vast library of healthy recipes.
In June 2024, Lifesum announced its transformative acquisition of LYKON, a leading biomarker-based personalized nutrition company in Germany. This strategic move aims to revolutionize Lifesum's service by integrating LYKON's pioneering technology, enabling users to access personalized nutrition and wellness recommendations based on medical-grade biomarker testing and analysis.
Key customers and partnerships
Lifesum has forged several notable partnerships to enhance its offerings and reach. In 2024, the company collaborated with Amazon to integrate its services with the Amazon Halo fitness tracker. Additionally, Lifesum partnered with Strong by Zumba, a prominent health club chain, further expanding its corporate customer base, which already includes over 100 companies as of June 2024.

Lifesum

Season Health is a food-as-medicine platform that offers personalized nutrition solutions to manage chronic conditions. Its services include tailored meal plans, pre-made meals, grocery support, one-on-one consultations with registered dietitians, and nutrition education. Season Health caters to payers and employers, addressing the growing prevalence of preventable chronic diseases linked to poor dietary habits. The company's approach involves translating clinical guidance into affordable, often subsidized food options integrated with payer benefits.
In November 2023, Season Health strategically acquired clinical assets from Wellory, expanding its provider network from dozens to hundreds of registered dietitians. This acquisition enabled Season Health to offer its services to Aetna and Cigna members, adding to its existing partnerships with UnitedHealthcare, Blue Cross Blue Shield of Arizona, and Geisinger. Season Health's technology platform supports health plans, providers, and employers seeking to implement food-as-medicine programs or leverage its marketplace solutions.
Season Health's evidence-based clinical nutrition programs have proven effective in improving health outcomes and reducing total cost of care. A recent report on the company's diabetes program revealed that members with an HbA1c level at or above nine points lowered their levels by an average of 1.8 points within 90 days of engaging with Season Health's registered dietitians and related clinical program.

Season Health

Providers of tailored dietary recommendations based on an individual's genetics and lifestyle for optimal wellness and disease prevention. This also includes calorie-counting apps that assist with weight loss and management

Designers of tailored dietary plans to address root causes of chronic diseases and symptom management

Companies that develop and offer supplements and nutraceuticals focused on enhancing health, addressing nutrition deficiencies and supporting overall wellness

Companies that provide personalized food services, including medically tailored meals and a marketplace for diverse dietary products to meet individual needs

Companies that offer virtual consultations from dietitians and nutritionists offering guidance via personalized nutrition plans, lifestyle and dietary assessments, and a focus on long-term health and wellness

Most functional nutrition companies offer nutrition solutions via digital mediums such as mobile applications; virtual consultations are also a part of the industry

Some functional nutrition offerings are based on the genomic profiles of individuals to identify personalized solutions

The products/platforms offered by most companies utilize AI/ML to enhance their offering

Most functional nutrition companies provide personalized nutrition solutions in the form of meal plans, supplements, and prepared meals

NutriSense

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless